Huons Meditech, the medical device specialist of Huons Group, is expanding its market presence by introducing its premium needle (injection needle) in China.


On April 8, Huons Meditech announced that it has recently completed registration of its skin booster-specific injection needle, the 'Premium 9-pin Needle,' with China's National Medical Products Administration (NMPA).

Sterile injection needle exclusively for skin booster "Premium 9-Pin Needle" packaging (left) and product (right) by Huons Meditech. Huons Meditech

Sterile injection needle exclusively for skin booster "Premium 9-Pin Needle" packaging (left) and product (right) by Huons Meditech. Huons Meditech

View original image

The 'Premium 9-pin Needle' is a dedicated injection needle designed to be used in conjunction with Huons Meditech's flagship aesthetic drug delivery devices, 'Dermashine Pro' and 'Dermashine Balance.'


The 'Premium 9-pin Needle' features a sophisticated structural design that enhances integration with the devices, enabling a stable procedure environment even under high-pressure drug injection conditions. In particular, by optimizing the inner diameter length of the needle, it allows for precise and deep delivery of even highly viscous substances into the skin without leakage, significantly reducing drug loss.


The convenience for both patients and practitioners has been greatly improved as well. The specialized bevel gear design minimizes pain and recovery time experienced by patients during procedures, while the dedicated protective cap helps prevent accidental needlestick injuries during use, thereby enhancing practitioner safety.


With this recent certification, Huons Meditech plans to expand its share in the global aesthetic market, including China, and continue introducing a portfolio of innovative medical devices.



Ha Chang-woo, CEO of Huons Meditech, stated, "By adding the innovative technology of the 'Premium 9-pin Needle' to the globally recognized 'Dermashine' platform, we have built a complete solution for aesthetic procedures. With NMPA approval, we aim to further strengthen our position as a trusted partner for aesthetic professionals in China and solidify our presence in the local skin booster market."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing